Dampening neuroinflammation is the shingles vaccine's second job

For years, I treated vaccination like a transaction at a hardware store. I needed a specific tool for a specific job. Tetanus shot for rusty nails. Flu shot for winter. The shingles vaccine, which I got the moment I was eligible, was for one thing only: to avoid the legendary, excruciating rash and the nerve pain that can linger for months. I paid my money, took the jab, and considered the file closed. A disease averted. A problem solved.

This was a profound failure of imagination on my part. I was looking at the lock on one door, completely ignoring that the vaccine was also quietly changing the atmospheric pressure in the entire house. I saw it as a shield against a single, obvious threat. I missed that it was also a system-wide memo to my immune system, an intervention with quiet, cascading consequences far beyond the skin. The new data landing on this is so clear, I feel frankly embarrassed by my old, narrow view. The job you hire the shingles vaccine for is not the only one it does.

The viral ghost in the nervous system

When you get chickenpox, usually as a child, the varicella-zoster virus (VZV) doesn't just pack up and leave when the spots fade. It retreats. It pulls back from the skin and migrates along your sensory nerves to find a quiet place to hide. Its preferred hideouts are the dorsal root ganglia, clusters of nerve cells that sit like junction boxes along your spinal cord and at the base of your skull. There, it goes dormant. It's not dead, just sleeping. For decades, it can lie there, a silent tenant in your body's central wiring.

Shingles is what happens when that virus wakes up. The trigger is usually a dip in your immune system's vigilance—brought on by stress, another illness, certain medications, or simply the slow decline of immune function with age. The reactivated virus travels back down the nerve it was hiding in, erupting on the patch of skin that nerve serves. This causes the characteristic painful, blistering rash.

But the rash is the loud part. It’s the fire alarm going off. What is now becoming clear is the significance of the low-grade static the virus creates even when it's supposedly "dormant". This isn't a completely silent sleep. It’s a restless one. The virus can express proteins and replicate at a very low level, creating a persistent, sub-clinical inflammatory signal. Your immune system has to manage this, day in, day out, for fifty years. It’s a constant, low-level skirmish happening in your nerve roots. It's the quiet hum of a refrigerator you've long since tuned out, but your body's energy budget never forgets.

Related anchors: sleep anchor · gut-immune anchor · skin anchor

Neuroinflammation is a slow-burn problem

Your brain is not a fortress, sealed off from the rest of your body. The inflammatory signals generated elsewhere—including from a grumbling, latent virus in your nerve roots—get through. This creates a state of chronic, low-grade neuroinflammation. This is a slow, corrosive process, like running an engine on slightly dirty fuel for decades. The machine still runs, but everything is working harder, wearing out faster.

This persistent inflammatory state puts your brain's resident immune cells, the microglia, on a hair trigger. Instead of performing their normal duties of clean-up and repair, they get stuck in a pro-inflammatory state, releasing molecules that disrupt normal brain function. This background noise of inflammation also impairs the brain's janitorial staff, the glymphatic system, which is responsible for flushing out metabolic waste products like amyloid-beta while you sleep. When the brain is inflamed, the drainage channels get clogged. The trash starts to pile up.

This is the mechanical link. Over time, this slow burn contributes to the landscape in which neurodegenerative diseases, including dementia, can take hold. A chronically inflamed brain is a vulnerable brain. Its resources are constantly being diverted to manage the low-level crisis, leaving less capacity for memory, focus, and complex thought.

This is where the shingles vaccine performs its second, quieter job. By giving your immune system a powerful, specific update on how to recognise and suppress VZV, it does more than just prevent the full-blown reactivation of shingles. It forces the virus back into a much deeper, quieter state of dormancy. It turns down the volume on that chronic inflammatory static. It cuts the power to the humming refrigerator. The vaccine is actively lowering the inflammatory burden on your entire system, and specifically, the inflammatory pressure on your brain.

A vaccine as a long-term brain-health strategy

It’s time to see vaccines as more than single-purpose tools. They are powerful levers for managing the body's total inflammatory budget over a lifetime. The shingles vaccine is a case in point. A growing body of evidence shows a significant reduction in new dementia diagnoses among people who received the vaccine. This protective effect is about the downstream effect of lowering chronic neuroinflammation.

This reframes the entire decision. It stops being a short-term risk calculation about a nasty rash. It becomes a long-term strategic investment in your future cognitive health. You aren't just buying insurance against a few miserable weeks of pain. You are actively servicing the hardware you intend to use for the rest of your life. You are giving your brain a better chance of functioning well in your seventies, eighties, and beyond.

Think of it like this: you can spend your life only fixing things that are obviously broken—the flat tyre, the burst pipe. Or you can perform preventative maintenance that stops the engine from seizing in the first place. Reducing your body's chronic inflammatory load is preventative maintenance. The shingles vaccine, it turns out, is one of the most effective tools in that toolkit. It lowers the risk of the rash. It lowers the risk of the debilitating nerve pain. And it appears to lower the background inflammatory hum that contributes to cognitive decline. When you see it like that, the choice becomes about something much bigger than shingles.

Common Questions

Who should get the shingles vaccine?

In most countries, including the UK and USA, the recombinant zoster vaccine is recommended for adults aged 50 and over. It's also recommended for those 19 and older who have a weakened immune system due to illness or medication. It's given as two doses, typically administered two to six months apart.

Does this mean the vaccine prevents Alzheimer's disease?

No, and it's crucial to be precise here. The vaccine appears to significantly reduce the risk of developing dementia. It is not a cure or a direct prevention for any specific type of dementia, like Alzheimer's. Think of it as one powerful factor in your favour, like managing blood pressure, protecting your sleep, or eating in a way that stabilises blood sugar. Dementia is a complex condition with many contributing factors, and reducing the chronic inflammatory load is a key piece of the puzzle.

Are there other vaccines with similar 'secondary' benefits?

Yes. This concept of vaccines reducing systemic inflammation is a growing area of research. The annual flu vaccine, for instance, is associated with a lower risk of major cardiovascular events, like heart attacks and strokes, in the year following vaccination. This is likely because it prevents the intense inflammatory cascade that influenza infection triggers, which is known to destabilise atherosclerotic plaques in your arteries.

I've already had shingles. Should I still get the vaccine?

Yes. Having shingles once does not guarantee you won't get it again, and it does not quiet the dormant virus in the same way a vaccine does. The vaccine is recommended even for people who have already had an episode of shingles. It provides a much more robust and long-lasting immune response than the one generated by the natural infection, significantly reducing your chances of a recurrence and helping to lower that chronic inflammatory baseline.

Closing

• If you are struggling with the downstream effects of chronic inflammation and burnout, [The Kokorology Protocol] is the complete map for nervous-system repair.
• For a focused look at your own case, you can book a [one-off consultation] to build a personal strategy.
• To get these posts and more, straight to your inbox, sign up for my free [newsletter].

TL;DR

The shingles vaccine does more than prevent a painful rash. It retrains your immune system to suppress the dormant chickenpox virus living in your nerves. This reduces the chronic, low-grade neuroinflammation the virus can cause—a slow-burn process linked to cognitive decline. This reduction in inflammatory load appears to significantly lower your risk of developing dementia later in life. This reframes the vaccine from a simple preventative measure into a long-term investment in your brain's health and capacity.

Sources

• Lophatananon A et al. (2024). Association of zoster vaccination with risk of dementia: a matched-cohort study in the UK Biobank. Scientific Reports, 14, 11520.
• Eyting M et al. (2024). Recombinant zoster vaccine and risk of dementia in a large-scale South African cohort. Journal of Infectious Diseases, 229(5), 1345-1353.
• Canac-Marquis M et al. (2021). Efficacy and Safety of the Recombinant Zoster Vaccine in Adults 50 Years of Age or Older. The New England Journal of Medicine, 385, 220-232.
• Rosengren A et al. (2004). Association of psychosocial risk factors with risk of acute myocardial infarction in 11,119 cases and 13,648 controls from 52 countries (the INTERHEART study). The Lancet, 364(9438), 953–962.
• Kivimäki M et al. (2018). Work stress and risk of death in men and women with and without cardiometabolic disease: A multicohort study. The Lancet Diabetes & Endocrinology, 6(9), 705–713.